I think the most app comparison is 4dx which has a $700 mil market cap and zero revenue so far from the commercialisation of its product.
4dx does have FDA approval. SGH is 2 years away from FDA approval but with an EV of 15 mil has considerable upside.
- Forums
- ASX - By Stock
- SHG
- IPO - Singular Health Group Ltd - 4 February 2021 #
IPO - Singular Health Group Ltd - 4 February 2021 #, page-25
Featured News
Add SHG (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.4¢ |
Change
0.002(2.44%) |
Mkt cap ! $17.36M |
Open | High | Low | Value | Volume |
8.1¢ | 8.4¢ | 7.8¢ | $49.03K | 600.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 35664 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.4¢ | 23626 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 35664 | 0.081 |
1 | 1 | 0.079 |
2 | 51550 | 0.075 |
1 | 12322 | 0.072 |
1 | 1601 | 0.070 |
Price($) | Vol. | No. |
---|---|---|
0.084 | 23626 | 2 |
0.090 | 326349 | 1 |
0.091 | 17878 | 1 |
0.092 | 11438 | 3 |
0.093 | 60000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
SHG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online